Coprescription of mood stabilizers in schizophrenia, dosing, and clinical correlates: An international study.
Wai Kwong LimQian Hui ChewYan-Ling HeTian-Mei SiFung-Kum Helen ChiuYu-Tao XiangTakahiro A KatoShigenobu KanbaNaotaka ShinfukuMin-Soo LeeSeon-Cheol ParkYong-Chon ParkMian-Yoon ChongShih-Ku LinShu-Yu YangAdarsh TripathiAjit AvasthiSandeep GroverRoy Abraham KallivayalilPichet UdomratnKok Yoon CheeAndi J TanraMd Golam RabbaniAfzal JavedSamudra KathiarachchiDulshika WaasWing Aung MyintNorman SartoriusVan Cuong TranKim Viet NguyenChay-Hoon TanRoss J BaldessariniKang SimPublished in: Human psychopharmacology (2020)
Schizophrenia patients receiving adjunctive MS treatment in Asian psychiatric centers are more severely ill and less responsive to simpler treatment regimens.